SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Andrew who wrote (1945)2/26/1999 2:15:00 PM
From: Steve Harmon  Read Replies (4) | Respond to of 2742
 
With the Techne deal Cistron now has between $13-14 million in cash and cash receivables. Not a mention of it anywhere in the news release.

Funny that a company with a market value of $5 million would not mention it.

Very funny.



To: Andrew who wrote (1945)6/1/1999 2:15:00 PM
From: Walter Morton  Read Replies (1) | Respond to of 2742
 
Genome explained CIST's products better than CIST does on its own WEB site.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News